Temporary Policy on Human Subjects Research-Related Visits
REVISED Temporary Policy on Human Subjects Research-Related Visits During COVID-19 Outbreak
and Further Suspension of Non-Essential In-Person Clinical Research Study Activities
University of Utah – Office of the Vice President for Research Effective March 28, 2020 re. Non-COVID Trials
The Office of the Vice President for Research is providing guidance related to human subjects-related research visits. This policy is being implemented to protect research participants, research personnel, and the larger University community from risk of infection from COVID-19, and to ensure continued access to clinical research that may provide essential therapies to participants. This revision aligns with the VPR Guidance of Essential Research Activities During the COVID-19 Outbreak, dated March 23, 2020.
Beginning March 28, 2020, the REVISED Human Subjects Research-Related Temporary Policy will be in place until further notice for the University of Utah.
- Participant research visits must be performed remotely (i.e., by phone, Zoom, or other means) whenever possible.
- If a research visit cannot be performed remotely, the principal investigator, in consultation
with the participant’s clinical care provider, should determine if the visit is essential
or not essential to the participant’s health and/or well-being.
- Study teams should contact participants prior to any in-person visit to determine whether the subject has fever or respiratory symptoms. If this is the case, they should be directed to schedule screening for COVID testing and the research visit should be postponed.
- Research visits that cannot be performed remotely and are essential to a participant's health and/or well-being may be performed in person. The visit should be accomplished outside University Hospital and Clinics in research compliant facilities if possible. Otherwise, participants should be made aware of how to access the University Hospital and Clinics facility for the visit, and provided with information about the current COVID-19 pandemic and how to reduce their risk of infection.
- Research visits that cannot be performed remotely and are not essential to a participant’s health and/or well-being should be postponed until further guidance.
- Enrollment of new patients on a clinical trial or other human subjects-related research should occur only if: 1) participation in the research is essential to a participant's health and/or well-being, as determined above; or 2) the enrollment and participant interactions can be conducted remotely for the duration of the COVID-19 outbreak.
- There may be studies that are not essential to a participant’s health and/or well-being but have research-only procedures that can be performed at a participant’s clinical or surgical visits at usual care (i.e., extra blood draws, sample collection, data collection, etc.). Research-only procedures at usual care visits may be performed during the outbreak at the discretion of the treating physician and care team. If the research-only procedures will impede or weaken protection of the participant, other patients, or the care team from COVID-19 exposure, the research-only procedures should not be performed.
- For necessary in-person visits we encourage visits to be relocated from University Hospitals and Clinics to research compliant space on campus. Please contact CCTS Nurse Manager Michelle Adams if you need assistance relocating your study activities from a clinical area of the UU Hospitals and Clinics to the Clinical Services Core of the CCTS, 421 Wakara Way. If you have questions about continuing clinical research, please contact CCTS Clinical Trials Support.
Featured Posts
Blog Archive
- Quarter1 2018 (1)
- April 2019 (26)
- August 2019 (17)
- December 2019 (10)
- February 2019 (25)
- July 2019 (14)
- June 2019 (16)
- March 2019 (17)
- May 2019 (13)
- November 2019 (8)
- October 2019 (20)
- September 2019 (14)
- April 2020 (13)
- August 2020 (10)
- December 2020 (11)
- February 2020 (12)
- January 2020 (10)
- July 2020 (9)
- June 2020 (7)
- March 2020 (30)
- May 2020 (10)
- November 2020 (15)
- October 2020 (21)
- September 2020 (19)
- April 2021 (10)
- August 2021 (21)
- December 2021 (12)
- February 2021 (17)
- January 2021 (10)
- July 2021 (11)
- June 2021 (17)
- March 2021 (21)
- May 2021 (14)
- November 2021 (16)
- October 2021 (15)
- September 2021 (16)
- April 2022 (8)
- August 2022 (9)
- February 2022 (14)
- January 2022 (9)
- July 2022 (14)
- June 2022 (12)
- March 2022 (22)
- May 2022 (14)
- September 2022 (0)
Notice: Undefined offset: 1 in /var/www/html/_resources/oublog/blog-functions.php on line 123
Tag Cloud
- COVID19 (7)
- VPR (5)
- PPE (1)
- EHS (1)
- Town Hall (1)
- RFP (1)
- 3i (1)
- SARS (1)
- Funding (7)
- Shipping (1)
- Policies (1)
- Procedures (1)
- human (2)
- subjects (2)
- research (3)
- visits (1)
- education (1)
- online (1)
- cores (1)
- funding (5)
- limited (1)
- pew (1)
- searle (1)
- diabetes (1)
- grant (1)
- mallinckrodt (1)
- immunology (1)
- inflamation (1)
- aging (1)
- extramural (1)
- NCATS (1)
- Corporate (3)
- foundation (1)
- Research (1)
- COVID-19 (1)
- Cancelled Events (2)
- Frontiers (2)
- Genomic Medicine (1)
- Dimensions AI (1)
- BCC (1)
- Databases (1)
- CCTS (1)
- Grants (1)
- Grant Review (1)
- Clinical Research (1)
- SOP (1)
- HSC (1)
- Limited submissions (1)
- Intramural (2)
- Foundations (2)
- FSGP (1)
- Medicine (1)
- Genomic (1)
- SoM (1)
- Publishing (1)
- Cabells (1)
- Authorship (1)
- AVPRI (1)
- NRMN (1)
- Grant Writing (1)
- Limited Submissions (1)
- Aging (1)
- CoA (1)